Skip to main content

Table 2 Immunohistochemical results for PON

From: Periostin expression and its supposed roles in benign and malignant thyroid nodules: an immunohistochemical study of 105 cases

 

MC

PAC

FC

PDCa

UCa

AG

FA

PON

S

CY

S

CY

S

CY

S

CY

S

CY

S

CY

S

CY

(++)

38%

0%

54%

0%

0%

0%

0%

0%

100%

0%

0%

0%

0%

0%

(+)

31%

0%

24%

0%

0%

0%

0%

0%

0%

100%

0%

0%

0%

0%

(F+)

15%

0%

15%

0%

28%

0%

100%

50%

0%

0%

10%

0%

17%

0%

(−)

15%

100%

7%

100%

72%

100%

0%

50%

0%

0%

90%

100%

83%

100%

fc

38%

N.A.

27%

N.A.

72%

N.A.

N.A.

N.A.

N.A.

N.A.

(20%)

N.A.

89%

N.A.

  1. *PON Periostin, MIC Microcarcinoma, PAC Papillary thyroidal carcinoma, FC Follicular carcinoma, PDCa Poorly differentiated carcinoma, UCa Undifferentiated carcinoma, AG Adenomatous goiter, FA Follicular adenoma
  2. *S Stroma, CY Cytoplasm, fc Fibrous capsule, (−) Negative [0%], (F+) Focally positive [1–9%], (+) Positive [10–49%], (++) Diffusely positive [≥50%], L.I. Labeling index, N.A. Not available